Nephrogenic diabetes insipidus (NDI) is the result of the resistance of the kidneys to AVP due to mutations in the gene-encoding AVP receptor 2 (AVPR2) or aquaporin 2 (AQP2), adverse drug effects, or electrolyte disorders [23]. The gene discussed is AQP2; the disease is nephrogenic diabetes insipidus.